| Revenue growth | 47.56% YoY consolidated growth in FY26. |
|---|---|
| Margins | Consolidated EBITDA margin at 36.13%; Standalone at 48.29%. |
| Demand visibility | Strong; driven by declining fertility rates and delayed parenthood. |
| Management confidence | High; citing category leadership and successful IPO listing. |
Growth
FY26 Consolidated Revenue grew 47.56% YoY; PAT grew 27.69% YoY. Standalone core IVF revenue rose 21.32% to ₹7,157.85 Lakhs.
Outlook
Aggressive expansion planned: 10 new hubs in FY27 (Delhi/Nagpur), 8 centers in FY28, and 1 in FY29.
Risks
Margins slightly contracted (PAT margin 27% to 23.5%) due to expansion and IPO-related capital changes.
Earnings Call filed with NSE, NSE: GAUDIUMIVF. Summary written with AI assistance from the document.
Gaudium IVF And Women Health Ltd: key numbers
- Share price
- ₹115.22
- Market cap
- ₹838.6 Cr
- Revenue (annual)
- ₹104.4 Cr
- Net profit (annual)
- ₹24.46 Cr
- P/E (TTM)
- 36.2×Sector 41.4×
- Promoter holding
- 71.29%+0.00% QoQ
- FII holding
- 3.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gaudium IVF And Women Health Ltd
All →Gaudium IVF And Women Health Capacity Expansion
Gaudium IVF and Women Health Limited commenced operations at its new IVF Centre/Hub in Gurgaon, Haryana, effective September 24, 2026.
- new IVF center
- 1.0 centers
Gaudium IVF And Women Health Other Announcement
Gaudium IVF and Women Health Limited has intimated the exchange about sending physical letters to shareholders for accessing the Annual Report for FY 2025-26.
Gaudium IVF And Women Health Annual Report
Gaudium IVF and Women Health Limited submitted its Annual Report for the Financial Year 2025-26. The 11th Annual General Meeting is scheduled for September 28, 2026.
Gaudium IVF And Women Health Annual General Meeting
Gaudium IVF and Women Health Limited will hold its 11th AGM on September 28, 2026. The meeting will be conducted via Video Conferencing to consider several resolutions.
Gaudium IVF And Women Health Investor Presentation: Key Takeaways
Gaudium IVF reported Q1 FY27 consolidated revenue of Rs. 1,937.66 Lakhs, up 9.13% YoY, while front-loading expansion costs for new hubs and AI integration.
Gaudium IVF And Women Health Q1 FY27 Results: Net Profit ₹1.8 Cr, Down 41.9% YoY
Gaudium IVF And Women Health Ltd reported revenue from operations of ₹19.4 Cr (+9.0% YoY) and net profit of ₹1.8 Cr (-41.9% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.8 Cr · -41.9% YoY